Deprescribing psychotropic medications in aged care facilities: The potential role of family members

Advances in Experimental Medicine and Biology

Volumn 821, Issue , 2015, Pages 29-43

  Plakiotis, Christos ^a   Simon Bell, J ^a,b,c   Jeon, Yun Hee ^d   Pond, Dimity ^e   O’Connor, Daniel W ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d UNIVERSITY OF SYDNEY   (Australia)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Aged care facilities; Dementia; Deprescribing; Older adults; Psychotropic medication

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ARTICLE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL PROTOCOL; DEPRESCRIBING; DRUG USE; EDUCATION PROGRAM; ELDERLY CARE; FAMILY ATTITUDE; HEALTH CARE POLICY; HUMAN; INAPPROPRIATE PRESCRIBING; MEDICAL HISTORY; MEDICAL RESEARCH; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; AGED; ATTITUDE TO HEALTH; AUSTRALIA; CAREGIVER; DEMENTIA; ETHICS; FAMILY; GERIATRIC ASSESSMENT; HOME FOR THE AGED; NURSING HOME; PATHOPHYSIOLOGY; PILOT STUDY; PSYCHOLOGY;

AGED; AUSTRALIA; CAREGIVERS; DEMENTIA; FAMILY; GERIATRIC ASSESSMENT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOMES FOR THE AGED; HUMANS; INAPPROPRIATE PRESCRIBING; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PSYCHOTROPIC DRUGS;

EID: 84912117694     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-319-08939-3_8     Document Type: Article

References (42)

1. Australian Institute of Health and Welfare (2013) Residential aged care and aged care packages in the community 2011–12 [Online]. http://www.aihw.gov.au/aged-care/residen tial-and-community-2011-12/. Accessed 11 Feb 2014
2. Hosia-Randell H, Pitkala K (2005) Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Aging 22(9):793–800
3. Snowdon J, Galanos D, Vaswani D (2011) Patterns of psychotropic medication use in nursing homes: surveys in Sydney, allowing comparisons over time and between countries. Int Psychogeriatr 23(9):1520–1525
4. Rattinger GB, Burcu M, Dutcher SK, Chhabra PT, Rosenberg PB, Simoni-Wastila L et al (2013) Pharmacotherapeutic management of dementia across settings of care. J Am Geriatr Soc 61(5):723–733
5. Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008) Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative study. Age Ageing 37(5):547–552
6. Kaur S, Mitchell G, Vitetta L, Roberts MS (2009) Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging 26(12):1013–1028
7. Brulhart MI, Wermeille JP (2011) Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm 33(3):549–557
8. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD (2013) Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 35 (1):51–56
9. Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S (2013) People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 61 (9):1508–1514
10. Reeve E, To J, Hendrix I, Shakib S, Roberts MS, Wiese MD (2013) Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 30(10):793–807
11. Woodward M (2003) Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 33(4):323–328
12. Alexander GC, Sayla MA, Holmes HM, Sachs GA (2006) Prioritizing and stopping prescription medicines. CMAJ 174(8):1083–1084
13. Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K et al (2009) Systematic review of interventions to improve prescribing. Ann Pharmacother 43(3):502–513
14. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG (2008) Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 56(10):1946–1952
15. Le Couteur D, Banks E, Gnjidic D, McLachlan A (2011) Deprescribing. Aust Prescr 34:182–185
16. Ostini R, Hegney D, Jackson C, Tett SE (2012) Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 18(1):68–72
17. Scott IA, Gray LC, Martin JH, Mitchell CA (2012) Minimizing inappropriate medications in older populations: a 10-step conceptual framework. Am J Med 125(6):529–537e4
18. Draper B, Brodaty H, Low LF (2006) A tiered model of psychogeriatric service delivery: an evidence-based approach. Int J Geriatr Psychiatry 21(7):645–653
19. Hartikainen S, Lonnroos E, Louhivuori K (2007) Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 62(10):1172–1181
20. Taipale HT, Bell JS, Gnjidic D, Sulkava R, Hartikainen S (2012) Sedative load among community-dwelling people aged 75 years or older: association with balance and mobility. J Clin Psychopharmacol 32(2):218–224
21. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS (2007) Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 176(5):627–632
22. The Royal Australian and New Zealand College of Psychiatrists (2009) Practice Guideline 10: Antipsychotic medications as a treatment of behavioural and psychological symptoms in dementia [Online]. https://www.ranzcp.org/Resources/Statements-Guidelines/Practice-Guide lines.aspx. Accessed 09 Feb 2014
23. Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML et al (2013) Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 3: CD007726
24. O’Connor DW, Griffith J, McSweeney K (2010) Changes to psychotropic medications in the six months after admission to nursing homes in Melbourne, Australia. Int Psychogeriatr 22 (7):1149–1153
25. Maguire A, Hughes C, Cardwell C, O’Reilly D (2013) Psychotropic medications and the transition into care: a national data linkage study. J Am Geriatr Soc 61(2):215–221
26. Azermai M, Vander Stichele RRH, Van Bortel LM, Elseviers MM (2013) Barriers to antipsychotic discontinuation in nursing homes: an exploratory study. Aging Ment Health 18:346–353. http://dx.doi.org/10.1080/13607863.2013.832732
27. Hilmer SN, Gnjidic D, Le Couteur DG (2012) Thinking through the medication list—appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 41 (12):924–928
28. The Department of Health (2012) Guiding principles for medication management in residential aged care facilities [Online]. http://www.health.gov.au/internet/main/publishing.nsf/Con tent/nmp-pdf-resguide-cnt.htm Accessed 09 Feb 2014
29. Tjia J, Gurwitz JH, Briesacher BA (2012) Challenge of changing nursing home prescribing culture. Am J Geriatr Pharmacother 10(1):37–46
30. Rovner BW, Edelman BA, Cox MP, Shmuely Y (1992) The impact of antipsychotic drug regulations on psychotropic prescribing practices in nursing homes. Am J Psychiatry 149 (10):1390–1392
31. Rendina N, Brodaty H, Draper B, Peisah C, Brugue E (2009) Substitute consent for nursing home residents prescribed psychotropic medication. Int J Geriatr Psychiatry 24(3):226–231
32. Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H et al (2004) An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 33(6):612–617
33. Nishtala PS, McLachlan AJ, Bell JS, Chen TF (2008) Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 16(8):621–632
34. Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP et al (2001) Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 51(3):257–265
35. Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P et al (2004) An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res 4(1):6
36. Westbury J, Jackson S, Gee P, Peterson G (2010) An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUSe project. Int Psychogeriatr 22(1):26–36
37. Westbury J, Tichelaar L, Peterson G, Gee P, Jackson S (2011) A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr 23(8):1260–1269
38. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F et al (2007) Designing and evaluating complex interventions to improve health care. BMJ 334(7591):455–459
39. National Health and Medical Research Council (2007) National statement on ethical conduct in human research (2007) - Updated December 2013 [Online]. http://www.nhmrc.gov.au/ guidelines/publications/e72. Accessed 09 Feb 2014
40. Alzheimer’s Australia (2013) Participate in research [Online]. http://www.fightdementia.org. au/research-publications/clinical-trials--research-projects.aspx. Accessed 09 Feb 2014
41. Gale NK, Heath G, Cameron E, Rashid S, Redwood S (2013) Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 13:117
42. Cumbler E, Wald H, Kutner J (2010) Lack of patient knowledge regarding hospital medications. J Hosp Med 5(2):83–86